Project description
Research training in technological development of scientific tools for cancer research
Funded by the Marie Skłodowska-Curie Actions programme, the TheraTools project will create a multidisciplinary research and training network to focus on the technological development of scientific tools to study malignant tumours localised beyond a biological barrier, as in the case of brain tumours. The TheraTools consortium will provide high-quality training opportunities across different disciplines, covering all stages of drug development, for nine early-stage researchers with the opportunity to obtain double doctorate degrees in two countries. The objective is to open enhanced career perspectives for young scientists in both the academic and non-academic sectors through international, interdisciplinary, and inter-sectorial mobility combined with an outstanding level of training.
Objective
TheraTools has arisen as a multidisciplinary research and training network that encompasses a full academical and technological view of the development of scientific tools for the comprehensive research of malignant tumors localized beyond a biological barrier, as in brain tumors. This challenging objective needs of the concerted effort of both academic and industrial organizations. As such, TheraTools is formed by a consortium composed by (a) four academic beneficiaries(POLYMAT-University of the Basque Country, Spain; University of Aveiro, Portugal; Italian Institute of Technology, linked to Sant´Anna School of Advanced Studies, Italy, and Technion – Israel Institute of Technology, Israel); and (b) 6 industrial partners: Polimerbio (Spain), BEONCHIP (Spain), Metatissue (Portugal), Vetex (Cyprus), I+Med (Spain), and Nanoscribe (Germany). All the partners will be involved in both research and training activities framed within this network.
TheraTools consortium and working plan has been configured to stablish a supportive network within a EJD in the topic of the development of “Innovative tools to treat and model complex cancer environments”. This network considers the engagement of 9 early-stage researchers that will have the opportunity to be awarded with double doctorate degrees in two different countries. TheraTools network will offer to the ESRs high quality training opportunities across several disciplines to conceive a full view of the development of therapeutics, from the synthesis of the drugs to their validation in in-vitro models. In its endeavor to translate the experience of the participants into products for health benefit, TheraTools will transfer the knowledge and competences to young researchers, providing them with enhanced career perspectives in both the academic and non-academic sectors through international, interdisciplinary, and inter-sectorial mobility combined with an innovation-oriented mindset and an excellence level of training.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-TMA-MSCA-DN-JD - HORIZON TMA MSCA Doctoral Networks - Joint Doctorates
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-MSCA-2021-DN-01
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
48940 LEIOA
Spain
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.